Victoria Wargon

562 citations
15 papers · 471 indexed · h-index 11
Topics
Estrogen and related hormone effects (10 papers)Cytokine Signaling Pathways and Interactions (5 papers)Cancer Cells and Metastasis (3 papers)

In The Last Decade

Victoria Wargon

15 papers receiving 466 citations

Peers

Victoria Wargon
Comparison fields: 5 of 66
  • Genetics 238
  • Oncology 213
  • Molecular Biology 196
  • Cancer Research 84
  • Immunology 40
Replace Reidun Aesöy with:
Reidun Aesöy Norway
Alison E. Obr United States
Shangle Qi Canada
Teresa A. Rose-Hellekant United States
Tina C. Lavranos Australia
Tracey E. Crew United Kingdom
M. Alkhalaf France
Mandy L. King United States
B. Valcaccia United Kingdom
Cristina Rodríguez-Burford United States
Victoria Wargon relative to Reidun Aesöy Norway Reidun Aesöy's profile →
Citations per field
00.5×5.2×
Reidun Aesöy · 1×
Citations per year

Countries citing papers authored by Victoria Wargon

Since Specialization
Citations

This map shows the geographic impact of Victoria Wargon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Wargon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Wargon more than expected).

Fields of papers citing papers by Victoria Wargon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Wargon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Wargon. The network helps show where Victoria Wargon may publish in the future.

Co-authorship network of co-authors of Victoria Wargon

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Wargon. A scholar is included among the top collaborators of Victoria Wargon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Wargon. Victoria Wargon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 33
2 28
3 6
4 19
5 79
6
エストロゲン受容体αは,サイクリンD1/MYCプロモーターにおいてプロゲステロン受容体と相互作用することにより,プロゲスチン誘発乳房腫瘍増殖を媒介する
1
7 68
8
[The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins].
10
9 27
10 25
11
Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasia.
9
12 11
13 82
14 30
15 43

About Victoria Wargon

Victoria Wargon is a scholar working on Oncology, Genetics and Toxicology, having authored 15 papers that have together received 471 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (10 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Genetics (238 citations), Oncology (213 citations) and Cancer Research (84 citations). Victoria Wargon has collaborated with scholars based in Argentina, United States and Sweden. Frequent co-authors include Claudia Lanari, Alfredo Molinolo, Sebastián Giulianelli, Paola Rojas, Luísa A. Helguero, Caroline A. Lamb, Rocío Soldati, Alfredo A. Molinolo, Oscar E. Pérez and Ana M.R. Pilosof. Their work appears in journals such as PLoS ONE, Cancer Research and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026